Head and Neck Neoplasms
📧 Sign up to get email alerts when something new happens for Head and Neck Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-01-28Clinical Trial Update: After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab Study
Clinical trial update for a study of induction chemotherapy with DP plus DDP concurrent radiotherapy, with and without bevacizumab, in head …
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Zalutumumab in Head and Neck Cancer [Phase 1, Phase 2]
Clinical trial update for zalutumumab in head and neck cancer across Phase 1 and Phase 2, with completed status and results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Robot Assisted Supraomohyoid Neck Dissection Via Retroauricular Approach [NA]
This document provides an update on a Yonsei University-sponsored clinical trial evaluating robot-assisted supraomohyoid neck dissection via…
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…
-
EMA withdrawal · 2009-07-23EMA Application withdrawn: Contusugene Ladenovec Gendux — Gendux Molecular Limited
The EMA withdrawal of the application for Contusugene Ladenovec Gendux by Gendux Molecular Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy [NA]
This clinical trial update evaluates the role of prophylactic antibiotics in new introducer PEG-Gastropexy for patients with head and neck n…